Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares stood at 0.42 million during the last session, with the company’s beta value hitting 1.19. At the close
During the last session, Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares were 0.25 million, with the beta value of the company hitting 1.18. At the
Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 1.32. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
